Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of Alberta

$1,407,600.00

The role of axonal GABA in facilitating proprioception, movement and recovery from spinal cord injury

FY 2025-26

Summary
Movement is guided by sensory feedback, which is especially important after spinal cord injury (SCI) when the control of movement by the brain is impaired. We recently discovered that GABAA receptors located on sensory axons are crucial for enabling sensory transmission toward motoneurons, aiding associated reflexes. This made us wonder whether axonal GABAA receptors are crucial for the more fundamental function of perception of limb position (proprioception), by facilitating sensory axon transmission toward the brain. Our pilot studies show that genetic ablation of axonal GABAA receptors leads to a dramatic loss of proprioception and movement accuracy, suggesting that targeting axonal GABA might be a promising approach for augmenting residual sensorimotor function after SCI. Thus, we will in Aim 1 examine the hypothesis that GABAA receptors on sensory axons are crucial for sensory transmission toward the brain, including after SCI. The experiments will involve recording from proprioceptive axons in the spinal cord of mice with GABA receptors genetically ablated. Then in Aim 2 we will examine the hypothesis that specialized GABAergic neurons and astrocytes provide the GABA that regulates the sensory axons, with astrocytes becoming critical after SCI. The experiments will involve optogenetically activating or inhibiting the GABAergic neurons or astrocytes. In Aim 3 we will examine the core hypothesis that axonal GABA is important for perception of movement, and treatments that augment neuronal and astrocyte sources of this GABA improve conduction and sensorimotor function in mice and humans, including clinically applicable pharmacological and nerve stimulation treatments. The experiments will measure movement accuracy in a ladder walking task in mice with genetic ablations of GABAergic circuits, and sensory transmission in mice and humans. In summary, augmenting axonal GABA with clinically applicable treatments may help restore proprioception and movement after SCI.
Program
Project Grant
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
562956
Name
Bennett David J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Movement & Exercise
Projecttitle
The role of axonal GABA in facilitating proprioception, movement and recovery from spinal cord injury
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$1,407,600
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Gaba; Motoneuron; Movement; Muscle; Proprioceptors; Spinal Cord Injury
Abstract
Movement is guided by sensory feedback, which is especially important after spinal cord injury (SCI) when the control of movement by the brain is impaired. We recently discovered that GABAA receptors located on sensory axons are crucial for enabling sensory transmission toward motoneurons, aiding associated reflexes. This made us wonder whether axonal GABAA receptors are crucial for the more fundamental function of perception of limb position (proprioception), by facilitating sensory axon transmission toward the brain. Our pilot studies show that genetic ablation of axonal GABAA receptors leads to a dramatic loss of proprioception and movement accuracy, suggesting that targeting axonal GABA might be a promising approach for augmenting residual sensorimotor function after SCI. Thus, we will in Aim 1 examine the hypothesis that GABAA receptors on sensory axons are crucial for sensory transmission toward the brain, including after SCI. The experiments will involve recording from proprioceptive axons in the spinal cord of mice with GABA receptors genetically ablated. Then in Aim 2 we will examine the hypothesis that specialized GABAergic neurons and astrocytes provide the GABA that regulates the sensory axons, with astrocytes becoming critical after SCI. The experiments will involve optogenetically activating or inhibiting the GABAergic neurons or astrocytes. In Aim 3 we will examine the core hypothesis that axonal GABA is important for perception of movement, and treatments that augment neuronal and astrocyte sources of this GABA improve conduction and sensorimotor function in mice and humans, including clinically applicable pharmacological and nerve stimulation treatments. The experiments will measure movement accuracy in a ladder walking task in mice with genetic ablations of GABAergic circuits, and sensory transmission in mice and humans. In summary, augmenting axonal GABA with clinically applicable treatments may help restore proprioception and movement after SCI.
Competitiondate
202603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Bennett, David J
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,407,600~ $0~
University of Alberta - $1,407,600 Grant (2025-26) | Canada Spends